glp 1 receptors in the brain Glucagon-like Peptide-1 and Central/Peripheral Nervous System: Crosstalk Diabetes: Trends in Endocrinology & Metabolism Nature: Dual-active molecules targeting GLP-1R

Learn about Januvia, a diabetes medication, its effects on weight loss, and how it compares to other treatments

Learn why rotating your injection sites matters, how to do it safely, and how Shotsy makes it effortless to track.

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight

These findings highlight the potential of high-potency GLP-1 agents as effective monotherapy options in managing obesity and glycemic control in adolescents.

Evidence-based comparison of retatrutide (GIP/GLP-1/glucagon triple agonist) and survodutide (GLP-1/glucagon dual agonist) for weight loss, MASH, and metabolic disease based on Phase 2 clinical trial data.

Start today!